B cells from these mice show normal ex vivo CSR and in vivo SHM, suggesting that FEN1 is not directly involved in Ig diversification-driven chromosomal aberrations linked to B-cell lymphomas, but rather, is involved in preventing DNA damage that is associated with the rapid proliferation of B cells in the GC. The gene discussed is FEN1; the disease is B-cell non-Hodgkin lymphoma.